Stage I Breast Cancer AJCC v7 Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0092280 (Stage I Breast Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs